Our results are similar to another proteomic study using P. aeruginosa; profiles at 1.5, 5.5 and 14.5 h after CIP treatment were evaluated, and neither LexA nor other SOS proteins were differentially expressed, except for RecA, which was found to be up-regulated87. The gene discussed is XYLT2; the disease is hereditary sensory and autonomic neuropathy.